DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Information source: Allergan
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Glaucoma, Open-Angle; Ocular Hypertension

Intervention: bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy) (Drug); Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution (Drug)

Phase: Phase 3

Status: Active, not recruiting

Sponsored by: Allergan

Official(s) and/or principal investigator(s):
Medical Director, Study Director, Affiliation: Allergan


This study will evaluate the safety and efficacy of Triple Combination Therapy compared with Fixed Combination brimonidine tartrate/timolol ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Intraocular Pressure (IOP)

Secondary outcome:









Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Ocular hypertension or primary open-angle glaucoma in each eye

- Requires treatment with IOP-lowering medication in both eyes

Exclusion Criteria:

- Required chronic use of ocular medications during the study other than study


- Use of any corticosteroids within 30 days

- History of any prior eye surgery, except for uncomplicated eye surgery performed more

than 6 months before the Screening visit

- Anticipated wearing of contact lenses during the study

Locations and Contacts

São Paulo, Brazil
Additional Information

Starting date: January 2011
Last updated: October 17, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017